ERBB2 and breast carcinoma: Overexpression of HER2, a tyrosine kinase transmembrane glycoprotein, can lead to abnormal proliferation and enhanced invasiveness of tumor cells in breast cancer patients, which accelerates the tumor progression and leads to poor prognosis [124].